Cargando…

Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening

SIMPLE SUMMARY: Over the past three decades, the incidence of thyroid cancer has been rising, with 90% being the well-differentiated thyroid cancer subtype. After diagnosis and surgical removal of the thyroid gland, radioactive iodine is administered to induce a localized post-operative radiation tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sondorp, Luc H.J., Ogundipe, Vivian M.L., Groen, Andries H., Kelder, Wendy, Kemper, Annelies, Links, Thera P., Coppes, Robert P., Kruijff, Schelto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692469/ https://www.ncbi.nlm.nih.gov/pubmed/33142750 http://dx.doi.org/10.3390/cancers12113212

Ejemplares similares

Patient-derived parathyroid organoids as a tracer and drug-screening application model
por: Noltes, Milou E., et al.
Publicado: (2022)

Generation and Differentiation of Adult Tissue-Derived Human Thyroid Organoids
por: Ogundipe, Vivian M.L., et al.
Publicado: (2021)

Postoperative external beam radiotherapy for locoregional control in iodine refractory differentiated thyroid cancer
por: Groen, Andries H, et al.
Publicado: (2021)

Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection
por: Jonker, Pascal K. C., et al.
Publicado: (2022)

Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancer
por: Rodriguez Schaap, Pedro Manuel, et al.
Publicado: (2023)

Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma
por: Creach, Kimberly M., et al.
Publicado: (2012)

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
por: Zhao, Hengqiang, et al.
Publicado: (2022)

The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas
por: Al-Kuraya, Khawla Sami, et al.
Publicado: (2021)

The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer
por: Wang, Xiaofei, et al.
Publicado: (2020)

The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma
por: van der Boom, Trynke, et al.
Publicado: (2021)

“Adjuvant Radioactive iodine 133 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience”
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2015)

The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER
por: Tang, Jianing, et al.
Publicado: (2018)

Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
por: Liu, Lina, et al.
Publicado: (2022)

Erratum to: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2016)

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
por: Hyogo, Yasuko, et al.
Publicado: (2018)

Assessment of different markers of ovarian reserve in women with papillary thyroid cancer treated with radioactive iodine
por: Adamska, Agnieszka, et al.
Publicado: (2021)

Responses to the First Radioactive Iodine Treatment After Targeted Therapy for Aggressive Papillary Thyroid Cancers
por: Soe, Myat Han, et al.
Publicado: (2021)

Changes in Gut Microbiota and Metabolites in Papillary Thyroid Carcinoma Patients Following Radioactive Iodine Therapy
por: Li, Wanting, et al.
Publicado: (2023)

Treating Hyperthyroidism with Radioactive Iodine
por: Harding, L K
Publicado: (1993)

Radioactive iodine and female fertility
por: Navarro, Pino, et al.
Publicado: (2022)

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial
por: Sawka, Anna M, et al.
Publicado: (2010)

Use of Salivary Iodine Concentrations to Estimate the Iodine Status of Adults in Clinical Practice
por: Dekker, Bernadette L, et al.
Publicado: (2021)

BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancer
por: Han, Sang-Ah, et al.
Publicado: (2014)

SAT569 Papillary Thyroid Carcinoma With Renal Metastasis Treated With Radioactive Iodine: A Case Report
por: Apa-Ap, Archimedes Almasol, et al.
Publicado: (2023)

Measurements on electromagnetically-separated radioactive isotopes of iodine
por: Aagaard, P, et al.
Publicado: (1957)

Papillary thyroid cancer recurrence 43 Years following Total Thyroidectomy and radioactive iodine ablation: a case report
por: Amoako-Tuffour, Yaw, et al.
Publicado: (2017)

Iodine Uptake in Retroperitoneal Cysts after Radioactive Iodine Treatment
por: Lee, Ji Young, et al.
Publicado: (2020)

Current and Future Perspectives of the Use of Organoids in Radiobiology
por: Nagle, Peter W., et al.
Publicado: (2020)

Insulin pump exposed to radioactive iodine
por: Magdaleno, Angela L., et al.
Publicado: (2018)

Radioactive Iodine Therapy and Glucose Tolerance
por: Samadi, Roghaieh, et al.
Publicado: (2017)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

Low-Iodine Diet of 4 Days Is Sufficient Preparation for (131)I Therapy in Differentiated Thyroid Cancer Patients
por: Dekker, Bernadette L, et al.
Publicado: (2021)

Radioactive Iodine Ablation Decrease Recurrences in Papillary Thyroid Microcarcinoma with Lateral Lymph Node Metastasis in Chinese Patients
por: Xue, Shuai, et al.
Publicado: (2017)

Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation
por: Ahn, Jonghwa, et al.
Publicado: (2020)

Treatment Response following Radioactive Iodine Therapy in Miliary versus Macronodular Pulmonary Metastases in Papillary Thyroid Carcinoma
por: Sunny, S. S., et al.
Publicado: (2022)

APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma
por: Siraj, Sarah, et al.
Publicado: (2022)

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer: update to study protocol with follow-up extension
por: Sawka, Anna M., et al.
Publicado: (2015)

The outcome of treatment in differentiated thyroid cancer according to recommendations in current Dutch and American guidelines
por: van Dijk, Deborah, et al.
Publicado: (2022)

Impact of lithium on radioactive iodine therapy for hyperthyroidism
por: Lingudu, Brahmanandam, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9iaq06v8ppb45kmr5c2c8bhg52